OVERVIEW

Contraceptive Update: The Centers for Disease Control and Prevention (CDC) Medical Eligibility Criteria (MEC) Contraception Guidelines and More is organized by Nurse Practitioner Associates for Continuing Education (NPACE).

Expiration Date: December 31st, 2025

Description:
In this dynamic presentation Dr. Mimi Secor DNP, FNP-BC, FAANP, FAAN, presents current challenges and trends in contraceptive management in 2024. Learners will understand medical eligibility criteria and the latest contraceptive research for prescribing considerations. Unique patient considerations, efficacy, patient needs, and other critical prescribing points are reviewed.

Learning Objectives:
After taking part in this educational activity, participants should be better able to:

  • Describe trends and contraceptive challenges facing clinicians and patients
  • Explain the new CDC medical eligibility criteria for prescribing various contraceptive methods and medical conditions.
  • Discuss new contraceptive research regarding efficacy, risks, benefits as this pertains to prescribing.
Credits

Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.

  • 1.5 Contact Hours
  • TARGET AUDIENCE

    PhysicianNursingInfectious Diseases Physician

    SPECIALITIES

    Infectious DiseaseMedical Education

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910